【Abstract】Objective?To explore the clinical value of electromagnetic navigation neuroendoscopic hematoma removal surgery combined with intracranial pressure monitoring and microscopic hematoma removal surgery in patients with basal ganglia hemorrhage. Methods?The clinical data of 84?patients with basal ganglia hemorrhage admitted to the First People’s Hospital of Kunshan from July 2021?to December 2022?was analyzed retrospectively, and they were divided into the experimental group (44?cases, electromagnetic navigation neuroendoscopic hematoma removal surgery combined with intracranial pressure monitoring) and the control group (40?cases, microscopic hematoma removal surgery), which accorded to different surgical methods. The perioperative related indicators, Glasgow coma scale (GCS) scores, clinical efficacy and brain edema volume between two groups were compared. Results?The frequency of mannitol use in the experimental group was less than that in the control group, the hematoma clearance rate was higher than that in the control group, the monitoring time and length of hospital stay were shorter than that in the control group, and the tracheotomy rate was lower than that in the control group (P<0.05). 24?hours after surgery, the GCS scores of the two groups of patients were higher than before surgery, and the score of the experimental group was higher than that of the control group (P<0.05). The Glasgow outcome scale (GOS) grading of the experimental group patients were better than that of the control group (P<0.05). 24?hours after surgery, volumes of brain edema in both groups of patients were smaller than before surgery, and the volume of the experimental group was smaller than that of the control group (P<0.05). Conclusion?The electromagnetic navigation neuroendoscope combined with intracranial pressure monitoring is more effective in the treatment of basal ganglia hemorrhage, which can improve perioperative related indicators, GCS score and GOS grading, and reduce brain edema volume.